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ABSTRACT To explore early intermediates in membrane fusion mediated by inﬂuenza virus hemagglutinin (HA) and their
dependence on the composition of the target membrane, we studied lipid mixing between HA-expressing cells and liposomes
containing phosphatidylcholine (PC) with different hydrocarbon chains. For all tested compositions, our results indicate the
existence of at least two types of intermediates, which differ in their lifetimes. The composition of the target membrane affects
the stability of fusion intermediates at a stage before lipid mixing. For less fusogenic distearoyl PC-containing liposomes at 4C,
some of the intermediates inactivate, and no intermediates advance to lipid mixing. Fusion intermediates that formed for the
more fusogenic dioleoyl PC-containing liposomes did not inactivate and even yielded partial lipid mixing at 4C. Thus, a more
fusogenic target membrane effectively blocks nonproductive release of the conformational energy of HA. Even for the same
liposome composition, HA forms two types of fusion intermediates, dissimilar in their stability and propensity to fuse. This
diversity of fusion intermediates emphasizes the importance of local membrane composition and local protein concentration in
fusion of heterogeneous biological membranes.
INTRODUCTION
Fusion of two membranes into one is a ubiquitous process in
living cells. Fusion mediated by hemagglutinin (HA), the
envelope glycoprotein of inﬂuenza virus, is one of the best-
characterized fusion reactions. To invade the cell, inﬂuenza
virus binds to sialic acid receptors at the cell surface, enters
the cell by endocytosis, and, ﬁnally, delivers viral RNA into
the cytosol by fusing the viral envelope and the endosome
membrane (1,2). This fusion reaction is triggered by acid-
iﬁcation of the endosome content and mediated by HA. The
surface of the virus is covered by HA trimers; each HA
monomer consists of two subunits, larger HA1 and smaller
HA2, connected by a single disulﬁde bond. The structure of
the initial neutral-pH conformation of HA and the restructur-
ing of HA at acidic pH have been characterized in detail
through different experimental approaches (1–5). The path-
way of HA-mediated fusion has been studied in different
experimental systems, including virus fusion to red blood
cells (RBC) and liposomes (6,7) as well as fusion of HA-
expressing cells (HA-cells) with RBC (8–10) and liposomes
(11–14). However, the mechanisms that couple low-pH-
dependent restructuring of HA and membrane rearrangement
remain elusive.
Conformational changes in acidiﬁed HA in the absence of
a target membrane result in HA inactivation, detected as a
decrease in the fusion rate after application of an additional
low-pH pulse in the presence of the target membrane (4,15).
Under fusion-inhibiting conditions (for instance, at low
temperature or in the presence of lysophosphatidylcholine
(LPC)), low-pH application to contacting HA-expressing
and target membranes yields interesting fusion intermediates
(6,10,16,17). Although these early fusion intermediates
allow neither lipid nor content mixing, the system is already
committed to fusion and will complete it at neutral pH, when
the inhibition is lifted. Low-pH-activated HAs do not main-
tain their fusogenic activity for an indeﬁnitely long time.
Fusogenicity of activated HAs decreases with time, as
evidenced by the gradual loss of fusion potential at the LPC-
arrested stage (17,18) and by the limited lifetime of early
fusion intermediates (19,20).
The contact area between the HA-cell and the RBC is
large enough to allow formation of multiple fusion sites
(19,21,22), complicating the detection of early fusion
intermediates. A fusion phenotype that is less advanced in
the hierarchy of fusion phenotypes, from restricted hemi-
fusion (neither lipid nor content mixing) to unrestricted
hemifusion (lipid mixing without content mixing) to com-
plete fusion (lipid and content mixing), is undetectable in the
presence of a more advanced phenotype. For instance, the
formation of a single expanding fusion pore in the contact
zone would not allow the detection of hundreds of hemifusion
sites present in the same contact zone. Under optimal fusion
conditions, the large contact zone between two fusing cells
contains multiple, diverse, and rapidly evolving fusion
intermediates.
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We are interested in the HA- and membrane-involving
intermediates, which precede lipid mixing and precede even
the irreversible commitment to eventual lipid mixing. Char-
acterization of the early intermediates might be facilitated by
decreasing the area of contact and slowing down the fusion
reaction. In this work, therefore, we replaced RBC, as target
membranes (8,10,23), with liposomes, and we inhibited the
fusion of HA-cells to liposomes by lowering the temperature
(10,16,24,25). Some stages of the conformational change in
HA are also slowed down or blocked under these conditions
(26,27).
To study the effects of the composition of the target mem-
brane on the evolution of the intermediates, for liposomes
containing the invariable molar percentages of phosphati-
dylcholine (PC), cholesterol, HA-receptor ganglioside, and
ﬂuorescent lipid probe, we varied the hydrocarbon chains of
the PC used (e.g., distearoyl PC, DSPC versus dioleoyl PC,
DOPC versus stearoyl-oleoyl PC, SOPC). For all tested com-
positions, our results indicate the existence of at least two
types of intermediates, which differ in their lifetimes. The
rate and direction of the progression from early intermediates
toward either lipid mixing or fusion inactivation differ signiﬁ-
cantly for different PCs, with the more ‘‘fusogenic’’ DOPC
effectively blocking nonproductive release of the conforma-
tional energy of HA.
MATERIALS AND METHODS
Materials
1,2-Distearoyl-sn-glycero-3-phosphatidylcholine (DSPC), 1,2-dioleoyl-sn-
glycero-3-phosphatidylcholine (DOPC), 1-stearoyl-2-oleoyl-sn-glycero-3-
phosphatidylcholine (SOPC), cardiolipin (CL; heart disodium salt), cholesterol,
1,2-dipalmitoyl-sn-glycero-3-phosphatidylethanolamine-N-(lissamine rho-
damine B sulfonyl) (RhDPPE), and 1,2-dioleoyl-sn-glycero-3-phosphati-
dylethanolamine-N-(lissamine rhodamine B sulfonyl) (RhDOPE) were
purchased from Avanti Polar Lipids (Alabaster, AL). Disialoganglioside
(GD1a) from bovine brain, citric acid, neuraminidase (EC 3.2.1.18, type V,
from Clostridium perfringens), and trypsin (EC 3.4.21.4, type IX, from
porcine pancreas) were purchased from Sigma Chemical (St. Louis, MO).
Methanol and sodium hydroxide were purchased from Mallinckrodt (Paris,
KY). Sodium chloride and benzene were purchased from Fisher Scientiﬁc
(Fair Lawn, NJ). Puriﬁed polyethylene glycol (PEG) 8000 (mol wt 7000–
9000) purchased from Fisher Scientiﬁc and puriﬁed as in Lentz et al. (28)
was a generous gift of Drs. Barry R. Lentz andMd. Emdadul Haque, Univer-
sity of North Carolina at Chapel Hill, Chapel Hill, NC.
HEPES was purchased from ICN Biomedicals (Aurora, OH). Triton
X-100 was purchased from Research Products International (Mount Prospect,
IL). Dulbecco’s phosphate-buffered saline (D-PBS) with Ca and Mg and
D-PBS without Ca or Mg were purchased from Bioﬂuids (Rockville, MD).
EGTA was purchased from Fluka (Buchs, Switzerland). EDTA was pur-
chased from Quality Biological (Gaithersburg, MD). Dulbecco’s modiﬁed
Eagle medium (DMEM), fetal bovine serum (FBS), and penicillin–strepto-
mycin–glutamine were purchased from Gibco BRL (Gaithersburg, MD).
Liposomes
Liposomes were prepared as described in Bailey and Cullis (29). In brief,
solutions of lipids (total amount 1 mmol) in benzene/methanol (95:5,
vol:vol) were dried and then hydrated to generate a 1 mM multilamellar
liposome suspension. After ﬁve freeze-thaw cycles, the vesicles were
extruded at 60C 10 times through two polycarbonate Nucleopore ﬁlters
(100-nm pore size) and one mesh spacer (Osmonics, Minnetonka, MN) in a
pressure extruder (Lipex Biomembranes, Vancouver, British Columbia,
Canada) to produce large unilamellar vesicles. After extrusion, liposomes
were diluted in a 1:4 ratio either with D-PBS (with Ca and Mg or without Ca
or Mg) buffer or with HEPES buffer (140 mM sodium chloride, 10 mM
HEPES, pH 7.4). The size of extruded liposomes (i.e.,;100 nm in diameter)
was veriﬁed by means of quasielastic light scattering on a Coulter N4 Plus
particle sizer (Beckman Coulter, Fullerton, CA).
Liposome compositions are stated as molar ratios between component
lipids. All compositions included 5% ﬂuorescent lipid probe and, if not
stated otherwise, 5% disialoganglioside, which serves as a receptor for HA
binding (30). DSPC/cholesterol liposomes (DSPC-LS) had the following
composition: 49.5% DSPC, 40.5% cholesterol, 5% RhDPPE, and 5%
disialoganglioside. DSPC-LS without disialoganglioside had the following
composition: 52.25% DSPC, 42.75% cholesterol, and 5% RhDPPE. SOPC/
cholesterol liposomes (SOPC-LS) were formed from a mixture of 49.5%
SOPC, 40.5% cholesterol, 5% RhDOPE, and 5% disialoganglioside. DOPC/
cholesterol liposomes (DOPC-LS) had the following composition: 49.5%
DOPC, 40.5% cholesterol, 5% RhDOPE, and 5% disialoganglioside. CL-
containing DSPC/cholesterol liposomes (DSPC/CL-LS) were formed from a
mixture of 46.75% DSPC, 38.25% cholesterol, 2.5% CL, 5% RhDPPE, and
5% disialoganglioside. (One CL molecule, with two polar heads and four
acid tails, was counted as the equivalent of two PC molecules.) Liposomes
were always used on the day of extrusion.
DSPC-LS and DOPC-LS without dye, used only in experiments studying
virus-liposome fusion and PEG-induced liposome-liposome fusion, had the
following composition: 52.25% PC (DSPC or DOPC), 42.75% cholesterol,
and 5% disialoganglioside.
Cells
CV-1 green monkey kidney cells were grown in DMEM supplemented with
10% FBS. CV-1 cells were infected 48 h before the experiment with SV40
recombinant viral vector containing Udorn HA-gene (inﬂuenza A/Udorn/72;
H3 subtype) (31,32), a generous gift of Dr. Robert A. Lamb, Northwestern
University, Evanston, IL. (Udorn strain has a very high degree of similarity,
;96%, to extensively studied X-31 strain.) Slightly subconﬂuent monolay-
ers of cells were incubated with SV40-HA stock at 37C, as described in
Melikyan et al. (23). After a 1-h incubation, the viral suspension was diluted
in a 1:6 ratio with DMEM complete medium. On the day of the experiment,
cells were treated for 15 min at 37C with trypsin (5 mg/ml) and neur-
aminidase (1 unit/ml) in D-PBS with Ca and Mg and washed twice with this
buffer. Then, cells were incubated with liposomes for 1 h at 4C and washed
ﬁve times, still at 4C, to remove unbound liposomes. After that, cells were
removed from the ﬂasks with Ca- and Mg-free D-PBS containing both
EDTA and EGTA at 0.5 mg/ml. EDTA- and EGTA-containing buffer was
removed, and cells were washed with cold (4C) buffer and then harvested
with ;3 ml of the same buffer.
Fusion of HA-cells with RBC
In some experiments, we studied HA-mediated fusion in a well-character-
ized experimental system of HA-cells fusing with labeled human red blood
cells (RBC). RBC were labeled with membrane dye PKH26 (Sigma
Chemical), and fusion experiments were performed as described earlier (10).
Fusion of HA-cells with liposomes
In most experiments, 600 ml of the suspension of cells with bound lipo-
somes (;105 cells and;53 109 liposomes) were incubated at pH 4.9, 4C,
for different durations, and then 500 ml of this suspension was mixed in a
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four-clear-sided methacrylate cuvette (Fisher Scientiﬁc) with 1.5 ml of
aqueous buffer, pH 7.4. As a result, our measurements were carried out at
neutral pH. Fluorescence was monitored for at least 4.5 min at the required
temperature with an Aminco Bowman Series 2 luminescence spectrometer
(Rochester, NY) with excitation at 530 nm and emission at 590 nm. The
medium in the cuvettes was continuously stirred with a magnetic stirring
device and thermostatted with a circulating water bath (Hoefer Scientiﬁc
Instruments, San Francisco, CA).
Because our liposomes contained ﬂuorescent lipid probe in a self-
quenched concentration, lipid mixing on fusion between liposomes and cells
diluted the probe and increased the observed ﬂuorescence. To quantify the
rates and extents of lipid mixing for different conditions, we measured the
ﬂuorescence of the samples (F) as a function of time and normalized it to
the ﬂuorescence (Fmax) measured on maximum dequenching by solubilizing
membranes with 1 mM Triton X-100 at the end of each experiment. The
percentage of lipid mixing was calculated as
%DF=DFmax ¼ 1003 ðF F0Þ=ðFmax  F0Þ;
where F0 is the ﬂuorescence of the suspension of cells with liposomes not
exposed to low pH at the onset of the measurements.
Each experiment presented here was repeated at least two times, and all
functional dependencies reported were observed in each experiment.
In some experiments, we evaluated liposome binding to the cells by
comparing the ﬂuorescence of cell-associated liposomes with the ﬂuores-
cence of a known amount of liposomes as described in Bailey et al. (14).
Liposome-liposome fusion mediated by PEG
A 500-ml sample of the 1:10 mixture of labeled and unlabeled liposomes
containing DOPC (or DSPC) and cholesterol was incubated at 4C at pH 7.4
and then mixed in a cuvette with 1.5 ml of the solution of PEG in aqueous
buffer. Fluorescence measurements were carried out at pH 7.4.
Virus-liposome fusion
In virus-liposome fusion experiments, we used DSPC-LS and DOPC-LS
formed from 52.25% PC (DSPC or DOPC), 42.75% cholesterol, and 5%
disialoganglioside. Liposomes were incubated in D-PBS with the viral
particles labeled with a self-quenching concentration of a membrane dye,
octadecyl rhodamine B (R18; Molecular Probes, Eugene, OR) (33). The
liposomes and viruses were incubated for 5 min at neutral pH to establish
virus-liposome binding and then placed into a pH-4.9 medium to trigger
fusion.
RESULTS
Inactivation and lipid mixing at 4C
Although lowering the temperature to 4C inhibits HA-
mediated fusion (10,16,25), it does not prevent the low-pH-
induced transition from the initial conformation to an acidic
form of HA. To study the functional inactivation of low-pH-
activated HAs in the presence of the target membrane, we
followed the changes in HA fusogenicity under fusion-
inhibiting conditions. We ﬁrst triggered HA-mediated fusion
in the presence of liposomes at 4C (low-pH pretreatment)
and then evaluated the fusogenic potential by measuring lipid
mixing after raising the temperature to 37C and simulta-
neously returning the pH to neutral. For DSPC-LS, there was
almost no lipid mixing at 4C (Fig. 1) and signiﬁcant lipid
mixing on a rise in the temperature (Fig. 2 A). For both
DSPC-LS and SOPC-LS, after low-pH application, a longer
incubation at 4C lowered the extent of lipid mixing at 37C
down to the level reached after a 15-min incubation at 4C at
pH 4.9. As shown in Fig. 2 C for DSPC-LS, the time traces
corresponding to different durations of incubation of HA-
cells with liposomes at pH 4.9 had similar shapes.
For DOPC-LS, signiﬁcant lipid mixing was observed at
4C (Fig. 1). Raising the temperature to 37C at neutral pH
yielded signiﬁcant additional lipid mixing (Fig. 3 A). In
contrast to DSPC-LS and SOPC-LS, DOPC-LS demon-
strated the same ﬁnal extent of lipid mixing at 37C regard-
less of the time of exposure to acidic pH at 4C (Fig. 3 A).
Although the extent of the lipid mixing at 37C for DSPC-LS
containing small amount of cardiolipin (2.5 mol %) de-
creased with an increase in the duration of the low-pH
incubation at 4C, this decrease was less profound than for
cardiolipin-free DSPC-LS (Fig. 3 B versus Fig. 2 A).
To emphasize the different patterns of functional inacti-
vation of low-pH-activated HAs (Fig. 2, A and B, and Fig. 3,
A and B), we plotted the dependences of the lipid-mixing
extents observed in representative experiments 4.5 min after
reneutralization and raising the temperature to 37C on the
duration of low-pH application (Fig. 4). Fusion rates varied
from day to day, with the highest variability observed for
SOPC-LS. However, the characteristic differences between
the patterns of fusion inactivation and the levels at which
lipid-mixing extent reached plateau for different liposome
compositions were observed in all experiments. At plateau,
the mean levels of ﬂuorescence (with standard deviations)
were 103.7 6 3.8% in the four experiments with DOPC-LS,
79.6 6 5.8% in the three experiments with DSPC/CL-LS,
67.9 6 15.1% in the three experiments with SOPC-LS, and
51.1 6 11.1% in the ﬁve experiments with DSPC-LS.
Statistical analysis (Student’s t-test) conﬁrms that the
differences between the extents of dequenching at plateau
FIGURE 1 Lipid mixing at 4C between HA-cells and DOPC-LS (curves
1 and 3), HA-cells and DSPC-LS (curves 2 and 4), recorded at pH 4.9
(curves 1 and 2; pH was lowered to 4.9 at the onset of measurements) and pH
7.4 (curves 3 and 4).
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for liposomes that demonstrate the lack of inactivation
(DOPC-LS) and partial inactivation (DSPC-LS and SOPC-
LS) are statistically signiﬁcant. The extents of dequenching
at plateau for DSPC-LS and SOPC-LS were statistically
different from DOPC-LS ( p ¼ 0.00004 and p ¼ 0.005, re-
spectively), and DSPC-LS signiﬁcantly differed from DSPC/
CL-LS (p ¼ 0.007). In contrast, the extents of dequenching
at plateau were statistically indistinguishable for DSPC-LS
and SOPC-LS (p ¼ 0.12) and for DSPC/CL-LS and SOPC-
LS (p ¼ 0.28).
One may hypothesize that, after pH-4.9 application, fusion
of DOPC-LS is too robust to allow detection of subtle
changes in the conditions (4), thus hindering the detection of
fusion inactivation with time at low pH. This possibility was
excluded by the experiment in which we lowered the number
of activated HAs by using less-acidic pH. Even at pH 5.7,
DOPC-LS still did not demonstrate any inactivation at 4C
(data not shown). Longer incubation at 4C did not decrease
lipid mixing measured at 37C and actually promoted lipid
mixing, perhaps by allowing more time for the formation of a
multi-protein fusion machine or fusion-committed interme-
diates (10).
In the experiments described above, after the onset of low-
pH application, the HA-cells with bound liposomes were
kept at low pH until the temperature was raised. The rate and
extent of lipid mixing observed at 37C after treatment of
cells with DSPC-LS at 4C with a 1-min pH-4.9 pulse
followed by 9 min at pH 7 were identical to those observed
after a 10-min pH-4.9 pulse applied at 4C rather than to
those observed after a 1-min pH-4.9 pulse immediately fol-
lowed by raising the temperature to 37C (data not shown).
One can hypothesize that fusion extent in the case of a 1-min
pH-4.9 pulse followed by 9 min at pH 7 is lowered by a de-
crease in the number of low-pH-activated HA molecules on
return of some of them at neutral pH to the initial confor-
mation. This, however, is not the case because the second
FIGURE 2 (A) Lipid mixing at 37C at
neutral pH between HA-cells and DSPC-LS
recorded without low-pH application (curve 1)
and after the following durations of incubation
at 4C at pH 4.9: 1 min (curve 2), 3 min (curve
3), 5 min (curve 4), 10 min (curve 5), 60 min
(curve 6). (B) Lipid mixing at 37C at neutral
pH between HA-cells and SOPC-LS recorded
without low-pH application (curve 1) and after
the following durations of incubation at 4C at
pH 4.9: 1 min (curve 2), 5 min (curve 3), 10
min (curve 4), 20 min (curve 5). (C) Lipid
mixing at 37C at neutral pH between HA-cells
and DSPC-LS, normalized to the level of
ﬂuorescence observed 10 min after raising the
temperature and recorded after the following
durations of incubation at 4C at pH 4.9: 1 min,
2 min, 3 min, 5 min, 10 min, 30 min, 60 min, 90
min (curves 1–8).
FIGURE 3 (A) Lipid mixing at 37C at
neutral pH between HA-cells and DOPC-LS
recorded without low-pH application (curve 1)
and after the following durations of incubation
at 4C at pH 4.9: 1 min (curve 2), 15 min (curve
3), 30 min (curve 4), and 60 min (curve 5). (B)
Lipid mixing at 37C at neutral pH between
HA-cells and DSPC/CL-LS recorded without
low-pH application (curve 1) and after the
following durations of incubation at 4C at pH
4.9: 2 min (curve 2), 5 min (curve 3), 15 min
(curve 4), 60 min (curve 5).
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1-min low-pH pulse (immediately before the raising of the
temperature) did not change the fusion extent (data not
shown). This ﬁnding indicates that, once triggered by low pH,
fusion inactivation proceeds at neutral pH.
In general, the relative fusogenicity of different liposome
compositions (DOPC-LS  SOPC-LS . DSPC-LS) was
conserved among three different experimental protocols: 1),
fusion triggered and observed at 4C, 2), fusion triggered and
observed at 37C (data not shown), and 3), fusion triggered
at 4C and observed at 37C. We also found DOPC-LS to be
more fusogenic than DSPC-LS both at 4C and at 37C for
PEG-induced liposome-liposome fusion (data not shown).
Thus, the greater extents of inactivation during low-pH
application at 4C for DSPC-LS versus DOPC-LS correlate
with lower fusogenicity of these liposomes.
Interestingly, neither of the liposome compositions stud-
ied matched the fusogenic properties of the RBC membrane,
the membrane most frequently used as a target for HA-
mediated fusion. Udorn HA-expressing cells with bound
RBC were treated at 4C with pH-5.2 pulses of different dura-
tions. As in the case of the fusion of HA-cells with DSPC-LS,
no lipid mixing was observed at 4C (similar results have been
reported for X-31 HA-expressing cells (10)). Warming low-
pH-treated RBC/HA-cell complexes to 37C at neutral pH
resulted in lipid mixing. The fusion extent detected increased
with an increase in the duration of the pH-5.2 pulse applied at
4C (Fig. 5). Thus, as in the case of the fusion of HA-cells
with DOPC-LS, there was no functional inactivation of HA
at 4C.
Despite the profound difference among the fusion patterns
for different liposome compositions, our results suggested an
important common trend. Partial dequenching of DOPC-LS
at 4C and partial inactivation of DSPC-LS at the same
temperature indicated that both DOPC-LS and DSPC-LS can
form fusion sites with radically different properties. One
might hypothesize that the different patterns of HA restruc-
turing, such as partial inactivation, observed for the same
liposome composition reﬂect different modes of liposome
binding: speciﬁc binding via the HA1-sialic acid connection
versus nonspeciﬁc binding. However, our ﬁnding that an
extension of the incubation time at pH 4.9, 4C, from 1 to 10
min for ganglioside-containing versus ganglioside-free
DSPC-LS resulted in a similar 1.6-fold inhibition of lipid
mixing at 37C (Fig. 6) argues against this possibility.
HA inactivation and interaction with the
target membrane
It has been hypothesized that insertion of the fusion peptides
of low-pH-restructured HA into the target membrane rather
than into HA-expressing membrane determines whether this
HA will fuse or undergo unproductive inactivation (34).
Along these lines, the effects of the lipid composition of the
target membranes on the inactivation or the lack of the
inactivation of HA at 4C might reﬂect the difference be-
tween the modes of interaction of the fusion peptide with
DOPC-LS versus DSPC-LS and SOPC-LS. Binding of the
fusion peptide to the target membrane can be detected as a
low-pH-induced increase in the binding of receptor-free lipo-
somes to HA-expressing membrane (6,35). We found that
low-pH-treated HA-cells bound similar numbers of gangli-
oside-free DOPC-LS and DSPC-LS. For 100-nm DOPC-LS
and DSPC-LS, the estimate gave ;69,000 and ;67,000
bound liposomes per cell, respectively (average of four experi-
ments for each composition). Thus, fusion peptides (and any
other regions of low-pH HA conformation that might reach
FIGURE 4 Lipid mixing at 37C at neutral pH between HA-cells and
liposomes is dependent on the duration of incubation at 4C at pH 4.9. The
percentage of ﬂuorescence dequenching of the lipid probe observed 4.5
min after raising the temperature is plotted as function of the duration of
incubation at 4C at pH 4.9, normalized to the level of ﬂuorescence after
incubation at pH 4.9 for 1 min. Liposomes are DOPC-LS (s), DSPC/CL-LS
(d), SOPC-LS (h), and DSPC-LS (n).
FIGURE 5 Lipid mixing between HA-cells and bound RBCs is dependent
on the duration of incubation of the cell pairs at pH 5.2 at 4C. After this
incubation, pH of the medium was returned to neutral, and simultaneously
the temperature was raised to 37C. The extent of fusion was measured 10
min after the low-pH application. Bars are mean 6 SE, n $ 3.
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the target membrane and bind to it) bind similarly to lipo-
somes of either composition.
Fusion of viral particles with liposomes
Liposomes of the same composition present different pat-
terns of fusion with HA-cells, as evidenced by partial fusion
for DOPC-LS and partial inactivation for DSPC-LS at 4C.
We hypothesized that the two distinct patterns of cell-
liposome fusion reﬂect an inhomogeneity of lateral distri-
bution of HA at the surface of the HA-cell. Fusion patterns
for individual liposomes associated with raft-like membrane
domains enriched in HA (36) are likely to differ from those
for liposomes associated with membrane carrying HA at a
lower density.
To test this hypothesis, we studied liposome fusion to inﬂu-
enza viral particles, which, in contrast to HA-cells, always
have HA at a density close to the highest surface density of
HA allowed by the protein sizes (37).
Prebound R18-labeled viral particles and liposomes were
treated with acidic pH at 4C for different durations. Then, at
the onset of measurements, the temperature was raised to
37C, and measurements were carried out still at pH 4.9.
However, some experiments were carried out at 4C; in these
experiments, pH was lowered to 4.9 at the onset of mea-
surements. Lipid mixing both at 4C and at 37C was de-
tected as R18 dequenching. Like liposome/HA-cell fusion,
liposome-virus fusion was dependent on liposome compo-
sition, with liposomes from DOPC/cholesterol being more
fusogenic than those from DSPC/cholesterol (Fig. 7). For
DOPC-LS, lipid mixing proceeded at 4C and reached an
extent even higher than that observed for virus/liposome
fusion at 37C (data not shown). Similar results have been
reported for virus fusion with liposomes and RBC (6,16,38).
For DSPC-LS, a low-pH application at 4C produced neither
lipid mixing nor fusion inactivation, detected as a decrease in
the ﬁnal lipid mixing observed after raising the temperature
to 37C. After a 45-min incubation at pH 4.9, raising the
temperature to 37C (still at pH 4.9) resulted in fusion
extents that were the same as or even higher than those found
when viruses-liposomes were pretreated with low pH for a
shorter time or were not low-pH-pretreated at all (Fig. 7 B).
Thus, in virus-liposome fusion for each of the two studied
liposome compositions, we found no indications of the exis-
tence of two distinct fusion patterns such as partial inactiva-
tion and partial fusion for DSPC-LS andDOPC-LS, respectively,
in liposome/HA-cell fusion.
DISCUSSION
At some stage of the fusion reaction, the properties of fusion
intermediates become sensitive to the properties of the target
membrane. In the absence of a target membrane, a low-pH
application rapidly inactivates HA (4,15,39), but in the
presence of the target membrane, when fusion is blocked by
LPC (17) or by low (4C) temperature (10), this low-pH-
dependent inactivation is strongly inhibited. How does the
presence of the target membrane inhibit HA inactivation? In
this work, we accumulated intermediates of cell-liposome
fusion at 4C and found that their evolution toward either
fusion or inactivation depends drastically on liposome
composition.
The time course of fusion inactivation observed for
ganglioside-containing liposomes was found to be identical
to that for ganglioside-free liposomes. Thus, HA1-receptor
interactions are not critical for the inhibition of inactivation
in the presence of the target membrane. With low-pH-
dependent receptor-independent binding of HA to the target
membrane taken as a measure of their interaction (6,35), the
similarity in binding of DOPC-LS and DSPC-LS to HA-cells
suggests that the difference between the patterns of fusion
and inactivation for these lipid compositions does not reﬂect
the difference between the ways in which the low-pH form of
HA binds to these liposomes. It still remains possible that the
angle of the fusion peptide insertion (40) and its functional
consequences vary with liposome composition. Fusion and
inactivation might also depend on the properties of the target
membrane downstream of its interaction with HA. The com-
position of the target membrane can be crucial for bringing
this membrane into tight contact and then fusing it with the
HA-expressing membrane.
Fusion at 4C
Although early stages of low-pH-triggered conformational
change in HA, including exposure of the fusion peptide and
FIGURE 6 Lipid mixing at 37C at neutral pH between HA-cells and
liposomes is dependent on the duration of incubation at 4C at pH 4.9.
The percentage of ﬂuorescence dequenching of the lipid probe observed 10
min after raising the temperature is plotted as a function of the duration of
incubation at 4C at pH 4.9. Dequenching for ganglioside-containing
DSPC-LS (d), dequenching for ganglioside-free DSPC-LS (n), ratio of
dequenching extents for ganglioside-containing and ganglioside-free DSPC-
LS (h).
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the kink region of the HA2 subunit, proceed rapidly (within a
minute) even at 4C (6), this temperature dramatically in-
hibits late stages of restructuring of HA, detected either as
dissociation of HA1 trimer or as functional inactivation of
HA treated with acidic pH in the absence of a target mem-
brane (6,26,27).
Fusion is also inhibited at 4C. In the case of inﬂuenza
virus fusing with RBC or fusogenic liposomes, there is slow
lipid mixing, reaching rather high extents, proceeding even
on reneutralization (6). X-31 viral particles fuse with large
unilamellar vesicles (LUVs) at pH 5.0, 3C (41), and with
RBCs at pH 4.8, 4C (16). In contrast, in the case of HA-cell
fusing with RBCs at 4C, there is no lipid mixing until the
temperature is raised (10). In this study, we reconstituted
both of these fusion phenotypes at 4C in fusion of HA-cells
with liposomes of different compositions: the complete
block of lipid mixing and slow lipid mixing. Thus, for the
same number of HA-cells, the phenotype of lipid mixing
depends on the properties of the target membrane.
Fusogenic properties and lipid composition
As reported earlier (17), the efﬁciency of HA-mediated
fusion depends on the lipid composition of the target
membrane. Different lipids can alter the fusogenicity of the
liposome membrane by different mechanisms. The effects of
the nonbilayer lipids on HA-mediated fusion and on many
other fusion reactions are, in general, consistent with the
predictions of the stalk-pore hypothesis, which suggests that
two subsequent fusion intermediates, a local hemifusion con-
nection (referred to as a stalk) and a fusion pore, are formed
by contacting and distal monolayers, respectively (9,10,
17,42). Gangliosides, known to serve as HA-receptors, likely
improve the quality (tightness and area) of the membrane
contact or directly affect the restructuring of HA (43).
Ganglioside GD1a promotes a slightly faster initial rate of
fusion than does GD1b (44). Bipolar lipids might inhibit
fusion stages, such as hemifusion, that require peeling of the
two monolayers of the same membrane from each other
(14,45).
For liposomes formed from the mixture of cholesterol and
different species of PC, liposomes containing PC with
unsaturated acyl chains support HA-mediated fusion better
than do liposomes formed of saturated lipid (this work and
46). We still do not know the speciﬁc mechanisms under-
lying the higher rates and extents of lipid mixing for DOPC-
versus SOPC- versus DSPC-containing liposomes. Although
our liposome compositions contained 5 mol % rhodamine-
labeled PE and 5 mol % disialoganglioside, we assume that
the mechanical properties of the bilayers and, in particular,
the differences in their fusogenicity were determined mainly
by the major components of the liposome composition: PC
and cholesterol. The concentration of cholesterol in the lipo-
somes used, 40.5 mol %, was chosen to mimic the compo-
sition typical for many biological membranes including RBC
(;40 mol % (47)). SOPC-containing bilayers, in a ﬁrst ap-
proximation, behave like many natural membranes. Indeed,
for the SOPC bilayer with 40 mol % cholesterol, the elastic
area compressibility modulus is rather close to that for
bilayers from RBC lipids including native cholesterol (;500
vs.;400 dyn/cm (47)). Although the majority of natural PC
molecules, as does SOPC, have one saturated and one unsat-
urated tail, two PC components studied in this work, DOPC
and DSPC, were chosen to represent certain extremes.
Because all these phospholipids share the same phospha-
tidylcholine polar group, any difference must be caused by
the acyl composition. DOPC, SOPC, and DSPC have very
different gel-to-liquid crystalline phase transition tempera-
tures (20, 6, and 55C, respectively). Published values of
the bending moduli, the elastic stretch moduli, and the
rupture tensions for cholesterol-free bilayers made of SOPC
and DOPC are much closer to each other than either is to
FIGURE 7 Lipid mixing between virus and DOPC-
LS (A) or DSPC-LS (B) was recorded at pH 4.9 at 37C
after R18-labeled viral particles with bound liposomes
were preincubated at pH 4.9 at 4C for 1 min, 5 min,
and 10 min (A) and 5 min, 15 min, and 45 min (B).
Recordings shown in blue and black represent exper-
iments without pretreatment (blue) and the experiments
where lipid mixing was detected at 4C (black). Note
that lipid mixing in the later experiments proceeded
much more slowly and thus is presented with a differ-
ent time scale.
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DSPC (48,49). Therefore, one can be surprised that SOPC-
containing bilayers were found to be much closer to DSPC-
than to DOPC-containing bilayers as the target membranes
in HA-mediated fusion at 4C. However, the mechanical
properties of the bilayers are profoundly changed by the pres-
ence of cholesterol. Cholesterol-phospholipid interaction
increases membrane cohesion, and, at ;50 mol %, choles-
terol is expected to signiﬁcantly decrease or abolish the
speciﬁc heat associated with the phase transition (50). The
curvature elasticity for SOPC membranes saturated with cho-
lesterol is;3-fold larger than that for cholesterol-free SOPC
membrane (51). Cholesterol also shifts the spontaneous
curvature of lipid monolayer to more negative values (52).
Although we do not know the exact difference between
the mechanical properties of the bilayers of the studied com-
positions at 4C, membranes containing PC with higher
degrees of unsaturation likely remain more deformable and,
in addition, have more negative spontaneous curvature.
Thus, DOPC/cholesterol bilayers are expected to form bent
fusion intermediates more readily and thus to support fusion
better than SOPC/cholesterol and DSPC/cholesterol bilayers.
Similarly, lipid bilayers of any composition are expected to
bend and to fuse more readily at 37C than at 4C. The
energy of fusion intermediates should be higher, and thus their
formation inhibited, for DSPC and at 4C than for DOPC and
at 37C. For lower energies, one may expect facilitated forma-
tion of the fusion intermediates.
Two distinct fusion intermediates
Low-pH application at 4C yielded potentially fusogenic
liposome-cell contacts (fusion intermediates) that differed in
their potential to advance to fusion. For DOPC-LS, some
55% of liposome-cell contacts yielded lipid mixing at 4C
after fusion for 1 h. The remaining 45% of the contacts
neither yielded fusion nor inactivated (these fusion interme-
diates yielded fusion after the temperature was raised). For
DSPC-LS, whereas half of fusion intermediates at 4C
inactivated with time at low pH, half remained stable and
produced lipid mixing after the temperature was raised.
These partial-fusion and partial-inactivation phenotypes in-
dicate that for each of the liposome compositions there are
two distinct types of fusion intermediates. One can hypoth-
esize that two kinds of HA intermediates (one for DOPS-LS,
and one for DSPC-LS), which neither inactivate nor yield
lipid mixing at 4C, can be identiﬁed as the same interme-
diate characterized by a particularly stable structure. How-
ever, signiﬁcant promotion of HA-cell/liposome fusion by
calcium chloride (5 mM) at 37C at neutral pH after
incubation at 4C at pH 4.9 for 30 or 60 min, from the stable
intermediate for DOPC-LS, and the absence of such a
promotion in the case of DSPC-LS (M. A. Zhukovsky and
L. V. Chernomordik, unpublished data), argues against such
a hypothesis. Examination of the fusion of viral particles
with liposomes also argues against the existence of such an
intermediate that neither inactivates nor yields lipid mixing
at 4C: in the case of DSPC-LS, no HAmolecules inactivate,
whereas in the case of DOPC-LS, all HA molecules that
yield lipid mixing at 37C also yield lipid mixing at 4C.
One can also hypothesize that for any composition of
target membrane, only one intermediate exists, and this
intermediate yields higher fusion with DOPC-LS than for
DSPC-LS because of inherent differences of fusogenicity of
lipids. However, it is difﬁcult to imagine that for the same
LS composition such a single intermediate produces partial
fusion or undergoes partial inactivation even after very long
incubations at 4C.
The two types of distinct fusion intermediates, and the
effects of the target membrane on their properties, might be
explained by the heterogeneity of the cell membrane and, in
particular, by heterogeneous distribution of HA molecules at
the cell surface. Because the surface density of fusion pro-
teins determines the rates, the extents, and even the phe-
notype of fusion, we hypothesize that for liposomes of the
same composition, fusion and inactivation patterns might
differ in a manner dependent on the local HA concentration
in the membrane patch under the liposome. We suggest that
liposomes bound at regions of the cell with a High Density of
HA (HD-HA sites) yield at 4C, in the case of DOPC-LS,
lipid mixing and, in the case of DSPC-LS, stable fusion
intermediates that do not inactivate with time but yield lipid
mixing only at 37C. In contrast, liposomes bound at the re-
gions with a Low Density of HA (LD-HA sites) yield, in the
case of DOPC-LS, fusion intermediates that do not support
lipid mixing at 4C but are stable and produce fusion on a
rise in the temperature to 37C. DSPC-LS at the LD-HA sites
establish short-lived intermediates that yield lipid mixing
only at 37C and only if low-pH incubation at 4C was
relatively short. We see that more fusogenic target mem-
brane and, possibly, higher HA surface density can prevent
HA inactivation at low temperatures. If we can assume that
both fusion and inactivation involve an irreversible confor-
mational change of HA (53), the increase in fusogenicity of
the target membrane or in HA surface density might favor
the fusion pathway versus the inactivation one.
The suggested relationship between fusion and inactiva-
tion patterns and local HA density is supported by the lack of
either partial lipid mixing or partial inactivation phenotypes
in liposome fusion to viral particles with a homogeneously
high density of HA. For both DSPC-LS and DOPC-LS,
fusion and inactivation at 4C were found to proceed as
expected for the given lipid composition, but only at sites
with high HA density. It would be interesting to study
another extreme: fusion of liposomes with the membrane
expressing homogeneously low density of HA. Unfortu-
nately, it is a very difﬁcult experiment: even for very low
average densities of HA molecules, some patches of the
membrane can always have high HA density.
A recent ﬁnding (54) suggests that our results are appli-
cable to other viruses: the efﬁciency of low-pH-dependent
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cell-cell fusion at 37C, mediated by Env, the fusion protein
of avian sarcoma and leukosis virus, was found to partially
decrease with an increase in time of incubation at 4C in the
presence of the target membrane after a low-pH triggering
event. This partial decrease could be a manifestation of the
presence of both low and high surface densities of fusion
proteins in this system.
The similarity of the shapes of the time traces correspond-
ing to fusion after different durations of incubation of HA-
cells with DSPC-LS at pH 4.9 (Fig. 2 C) can be explained in
the following way. The transition from early and reversible
conformation(s) of low-pH-activated HA toward an irre-
versible protein conformation underlies both HA-mediated
fusion and HA inactivation (4,27). Inactivation of LD-HA
molecules with time at 4C results in transition of LD-HA
molecules from a reversibly activated to an inactivated
conformation. It causes reduction in the number of fusion
machines available for fusion at 37C but does not change
the efﬁciency of fusion mediated by these fusion machines at
this temperature.
To conclude, we explored here the diversity of the fusion
intermediates formed by HA at different temperatures and
for different target membranes. We found that even for the
same target membrane composition, at low (4C) tempera-
ture HA forms two types of intermediates: HD and LD.
Intermediate HD is more stable and more fusogenic than LD;
behavior of the system at 4C also depends on the com-
position of the target membrane. The diversity of the fusion
intermediates formed in different contact sites might reﬂect
the heterogeneous distribution of HA in the cell membrane.
This diversity is likely a general feature of the biological
membrane fusion reaction (19) because biological mem-
branes are heterogeneous in their lipid composition and in
the distribution of proteins that regulate fusion (for instance,
receptors that trigger conformational change of the fusion
proteins such as human immunodeﬁciency virus (HIV) Env),
and fusion proteins themselves.
The authors acknowledge helpful discussions with Drs. Vadim Frolov,
Mikhail Kozlov, Kamran Melikov, and Joshua Zimmerberg. The authors
also thank Dr. Robert A. Lamb (Northwestern University, Evanston, IL) for
SV40 recombinant viral vector and Drs. Barry R. Lentz and Md. Emdadul
Haque (University of North Carolina at Chapel Hill, Chapel Hill, NC) for
puriﬁed polyethylene glycol (PEG).
This research was supported by the Intramural Research Program of the
National Institutes of Health, National Institute of Child Health and Human
Development.
REFERENCES
1. White, J. M. 1995. Membrane fusion: The inﬂuenza paradigm. Cold
Spring Harb. Symp. Quant. Biol. 60:581–588.
2. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and mem-
brane fusion in virus entry: The inﬂuenza hemagglutinin. Annu. Rev.
Biochem. 69:531–569.
3. Skehel, J. J., P. M. Bayley, E. B. Brown, S. R. Martin, M. D.
Waterﬁeld, J. M. White, I. A. Wilson, and D. C. Wiley. 1982. Changes
in the conformation of inﬂuenza virus hemagglutinin at the pH op-
timum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA.
79:968–972.
4. Markovic, I., E. Leikina, M. Zhukovsky, J. Zimmerberg, and L. V.
Chernomordik. 2001. Synchronized activation and refolding of inﬂu-
enza hemagglutinin in multimeric fusion machines. J. Cell Biol. 155:
833–844.
5. Tamm, L. K., J. Crane, and V. Kiessling. 2003. Membrane fusion: a
structural perspective on the interplay of lipids and proteins. Curr.
Opin. Struct. Biol. 13:453–466.
6. Stegmann, T., J. M. White, and A. Helenius. 1990. Intermediates in
inﬂuenza induced membrane fusion. EMBO J. 9:4231–4241.
7. Shangguan, T., D. Alford, and J. Bentz. 1996. Inﬂuenza virus-liposome
lipid mixing is leaky and largely insensitive to the material properties
of the target membrane. Biochemistry. 35:4956–4965.
8. Kemble, G. W., T. Danieli, and J. M. White. 1994. Lipid-anchored
inﬂuenza hemagglutinin promotes hemifusion, not complete fusion.
Cell. 76:383–391.
9. Melikyan, G. B., S. A. Brener, D. C. Ok, and F. S. Cohen. 1997. Inner
but not outer membrane leaﬂets control the transition from glyco-
sylphosphatidylinositol-anchored inﬂuenza hemagglutinin-induced
hemifusion to full fusion. J. Cell Biol. 136:995–1005.
10. Chernomordik, L. V., V. A. Frolov, E. Leikina, P. Bronk, and
J. Zimmerberg. 1998. The pathway of membrane fusion catalyzed by
inﬂuenza hemagglutinin: restriction of lipids, hemifusion, and lipidic
fusion pore formation. J. Cell Biol. 140:1369–1382.
11. van Meer, G., J. Davoust, and K. Simons. 1985. Parameters affecting
low-pH-mediated fusion of liposomes with the plasma membrane of
cells infected with inﬂuenza virus. Biochemistry. 24:3593–3602.
12. Ellens, H., S. Doxsey, J. S. Glenn, and J. M. White. 1989. Delivery of
macromolecules into cells expressing a viral membrane fusion protein.
Methods Cell Biol. 31:155–178.
13. Ellens, H., J. Bentz, D. Mason, F. Zhang, and J. M. White. 1990.
Fusion of inﬂuenza hemagglutinin-expressing ﬁbroblasts with glyco-
phorin-bearing liposomes: role of hemagglutinin surface density. Bio-
chemistry. 29:9697–9707.
14. Bailey, A., M. Zhukovsky, A. Gliozzi, and L. V. Chernomordik. 2005.
Liposome composition effects on lipid mixing between cells expressing
inﬂuenza virus hemagglutinin and bound liposomes. Arch. Biochem.
Biophys. 439:211–221.
15. Puri, A., F. P. Booy, R. W. Doms, J. M. White, and R. Blumenthal.
1990. Conformational changes and fusion activity of inﬂuenza virus
hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment.
J. Virol. 64:3824–3832.
16. Schoch, C., R. Blumenthal, and M. J. Clague. 1992. A long-lived state
for inﬂuenza virus-erythrocyte complexes committed to fusion at
neutral pH. FEBS Lett. 311:221–225.
17. Chernomordik, L. V., E. Leikina, V. Frolov, P. Bronk, and
J. Zimmerberg. 1997. An early stage of membrane fusion mediated
by the low pH conformation of inﬂuenza hemagglutinin depends upon
membrane lipids. J. Cell Biol. 136:81–94.
18. Leikina, E., I. Markovic, L. V. Chernomordik, and M. M. Kozlov.
2000. Delay of inﬂuenza hemagglutinin refolding into a fusion-com-
petent conformation by receptor binding: A hypothesis. Biophys. J. 79:
1415–1427.
19. Leikina, E., and L. V. Chernomordik. 2000. Reversible merger of mem-
branes at the early stage of inﬂuenza hemagglutinin-mediated fusion.
Mol. Biol. Cell. 11:2359–2371.
20. Mittal, A., E. Leikina, L. V. Chernomordik, and J. Bentz. 2003.
Kinetically differentiating inﬂuenza hemagglutinin fusion and hemi-
fusion machines. Biophys. J. 85:1713–1724.
21. Frolov,V.,M. S. Cho, P. Bronk, T. Reese, and J. Zimmerberg. 2000.Mul-
tiple local contact sites are induced by GPI-linked inﬂuenza hemagglu-
tinin during hemifusion and ﬂickering pore formation.Trafﬁc. 1:622–630.
22. Leikina, E., A. Mittal, M. S. Cho, K. Melikov, M. M. Kozlov, and
L. V. Chernomordik. 2004. Inﬂuenza hemagglutinins outside of the
Heterogeneity of Intermediates in Fusion 3357
Biophysical Journal 91(9) 3349–3358
contact zone are necessary for fusion pore expansion. J. Biol. Chem.
279:26526–26532.
23. Melikyan, G. B., H. Jin, R. A. Lamb, and F. S. Cohen. 1997. The role
of the cytoplasmic tail region of inﬂuenza virus hemagglutinin in
formation and growth of fusion pores. Virology. 235:118–128.
24. Melikyan, G. B., R. M. Markosyan, H. Hemmati, M. K. Delmedico,
D. M. Lambert, and F. S. Cohen. 2000. Evidence that the transition of
HIV-1 gp41 into a six-helix bundle, not the bundle conﬁguration, induces
membrane fusion. J. Cell Biol. 151:413–423.
25. Markosyan, R. M., G. B. Melikyan, and F. S. Cohen. 2001. Evolution
of intermediates of inﬂuenza virus hemagglutinin-mediated fusion
revealed by kinetic measurements of pore formation. Biophys. J. 80:
812–821.
26. White, J. M., and I. A. Wilson. 1987. Anti-peptide antibodies detect
steps in a protein conformational change: low-pH activation of the
inﬂuenza virus hemagglutinin. J. Cell Biol. 105:2887–2896.
27. Leikina, E., C. Ramos, I. Markovic, J. Zimmerberg, and L. V.
Chernomordik. 2002. Reversible stages of the low-pH-triggered
conformational change in inﬂuenza virus hemagglutinin. EMBO J.
21:5701–5710.
28. Lentz, B. R., G. F. McIntyre, D. J. Parks, J. C. Yates, and
D. Massenburg. 1992. Bilayer curvature and certain amphipaths pro-
mote poly(ethylene glycol)-induced fusion of dipalmitoylphosphati-
dylcholine unilamellar vesicles. Biochemistry. 31:2643–2653.
29. Bailey, A. L., and P. R. Cullis. 1997. Membrane fusion with cationic
liposomes: effects of target membrane lipid composition. Biochemistry.
36:1628–1634.
30. Slepushkin, V. A., A. I. Starov, A. G. Bukrinskaya, A. B. Imbs, M. A.
Martynova, L. S. Kogtev, E. L. Vodovozova, N. G. Timofeeva, J. G.
Molotkovsky, and L. D. Bergelson. 1988. Interaction of inﬂuenza virus
with gangliosides and liposomes containing gangliosides. Eur. J.
Biochem. 173:599–605.
31. Jin, H., G. P. Leser, and R. A. Lamb. 1994. The inﬂuenza virus hemag-
glutinin cytoplasmic tail is not essential for virus assembly or infectivity.
EMBO J. 13:5504–5515.
32. Jin, H., K. Subbarao, S. Bagai, G. P. Leser, B. R. Murphy, and R. A.
Lamb. 1996. Palmitylation of the inﬂuenza virus hemagglutinin (H3) is
not essential for virus assembly or infectivity. J. Virol. 70:1406–1414.
33. Hoekstra, D., T. de Boer, K. Klappe, and J. Wilschut. 1984. Fluo-
rescence method for measuring the kinetics of fusion between biological
membranes. Biochemistry. 23:5675–5681.
34. Weber, T., G. Paesold, C. Galli, R. Mischler, G. Semenza, and
J. Brunner. 1994. Evidence for H(1)-induced insertion of inﬂuenza
hemagglutinin HA2 N-terminal segment into viral membrane. J. Biol.
Chem. 269:18353–18358.
35. Gu¨nther-Ausborn, S., A. Praetor, and T. Stegmann. 1995. Inhibition of
inﬂuenza-induced membrane fusion by lysophosphatidylcholine. J. Biol.
Chem. 270:29279–29285.
36. Scheiffele, P., M. G. Roth, and K. Simons. 1997. Interaction of
inﬂuenza virus haemagglutinin with sphingolipid-cholesterol mem-
brane domains via its transmembrane domain. EMBO J. 16:5501–5508.
37. Wiley, D. C., and J. J. Skehel. 1987. The structure and function of the
hemagglutinin membrane glycoprotein of inﬂuenza virus. Annu. Rev.
Biochem. 56:365–394.
38. Pak, C. C., M. Krumbiegel, and R. Blumenthal. 1994. Intermediates
in inﬂuenza virus PR/8 haemagglutinin-induced membrane fusion.
J. Gen. Virol. 75:395–399.
39. Korte, T., K. Ludwig, F. P. Booy, R. Blumenthal, and A. Herrmann.
1999. Conformational intermediates and fusion activity of inﬂuenza
virus hemagglutinin. J. Virol. 73:4567–4574.
40. Epand, R. M., R. F. Epand, I. Martin, and J. M. Ruysschaert. 2001.
Membrane interactions of mutated forms of the inﬂuenza fusion peptide.
Biochemistry. 40:8800–8807.
41. Tsurudome, M., R. Gluck, R. Graf, R. Falchetto, U. Schaller, and J.
Brunner. 1992. Lipid interactions of the hemagglutinin HA2 NH2-
terminal segment during inﬂuenza virus-induced membrane fusion.
J. Biol. Chem. 267:20225–20232.
42. Chernomordik, L. 1996. Non-bilayer lipids and biological fusion
intermediates. Chem. Phys. Lipids. 81:203–213.
43. Stegmann, T., I. Bartoldus, and J. Zumbrunn. 1995. Inﬂuenza
hemagglutinin-mediated membrane fusion: inﬂuence of receptor bind-
ing on the lag phase preceding fusion. Biochemistry. 34:1825–1832.
44. Ramalho-Santos, J., and M. C. Pedroso de Lima. 2004. The role of
target membrane sialic acid residues in the fusion activity of the
inﬂuenza virus: The effect of two types of ganglioside on the kinetics
of membrane merging. Cell. Mol. Biol. Lett. 9:337–351.
45. Relini, A., D. Cassinadri, Q. Fan, A. Gulik, Z. Mirghani, M. De Rosa,
and A. Gliozzi. 1996. Effect of physical constraints on the mechanisms
of membrane fusion: bolaform lipid vesicles as model systems.
Biophys. J. 71:1789–1795.
46. Kawasaki, K., and S. Ohnishi. 1992. Membrane fusion of inﬂuenza
virus with phosphatidylcholine liposomes containing viral receptors.
Biochem. Biophys. Res. Commun. 186:378–384.
47. Needham, D., and R. S. Nunn. 1990. Elastic deformation and failure of
lipid bilayer membranes containing cholesterol. Biophys. J. 58:997–
1009.
48. Hunter, D. G., and B. J. Frisken. 1998. Effect of extrusion pressure
and lipid properties on the size and polydispersity of lipid vesicles.
Biophys. J. 74:2996–3002.
49. Rawicz, W., K. C. Olbrich, T. McIntosh, D. Needham, and E. Evans.
2000. Effect of chain length and unsaturation on elasticity of lipid
bilayers. Biophys. J. 79:328–339.
50. Ladbrooke, B. D., R. M. Williams, and D. Chapman. 1968. Studies on
lecithin-cholesterol-water interactions by differential scanning calorim-
etry and X-ray diffraction. Biochim. Biophys. Acta. 150:333–340.
51. Song, J., and R. E. Waugh. 1993. Bending rigidity of SOPC mem-
branes containing cholesterol. Biophys. J. 64:1967–1970.
52. Chen, Z., and R. P. Rand. 1997. The inﬂuence of cholesterol on
phospholipid membrane curvature and bending elasticity. Biophys. J.
73:267–276.
53. Carr, C. M., C. Chaudhry, and P. S. Kim. 1997. Inﬂuenza hemagglu-
tinin is spring-loaded by a metastable native conformation. Proc. Natl.
Acad. Sci. USA. 94:14306–14313.
54. Markosyan, R. M., P. Bates, F. S. Cohen, and G. B. Melikyan.
2004. A study of low pH-induced refolding of Env of avian sar-
coma and leukosis virus into a six-helix bundle. Biophys. J. 87:3291–
3298.
3358 Zhukovsky et al.
Biophysical Journal 91(9) 3349–3358
